GRPR antagonists for prostate cancer--prospects and caveats.

about

GRPR antagonists for prostate cancer--prospects and caveats.

Item

http://www.wikidata.org/entity/Q50881807

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

GRPR antagonists for prostate cancer--prospects and caveats.

@en

GRPR antagonists for prostate cancer--prospects and caveats.

@nl

type

Item

label

GRPR antagonists for prostate cancer--prospects and caveats.

@en

GRPR antagonists for prostate cancer--prospects and caveats.

@nl

prefLabel

GRPR antagonists for prostate cancer--prospects and caveats.

@en

GRPR antagonists for prostate cancer--prospects and caveats.

@nl

P1476

GRPR antagonists for prostate cancer--prospects and caveats

@en

P2093

Rafael Roesler

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroendocrine cells in prostate cancer.

Targeting GRPR in urological cancers--from basic research to clinical application.

Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models.

Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies.

Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates.

P2888

nrurol.2013.42-c1

P304

424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRUROL.2013.42-C1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gilberto Schwartsmann

R Roesler

P577

2013-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23797339

http://www.w3.org/2001/XMLSchema#string